DC101
Description: DC101 is a monoclonal antibody used experimentally to block VEGFR2 and inhibit angiogenesis in biomedical research.
Primary topic: Angiogenesis and VEGF in Cancer (55%)
Related topic: Angiogenesis and VEGF in Cancer (55%)
OpenAlex ID: keywords/dc101
